Texto: 
CT is ordered.
The mass was excised and patient recovered without recurrence.
Fig. 1 Coronal T1-weighted MR image which shows the well-defined, fairly homogeneous mass which is slightly hypointense to the adjacent liver (red arrow). Note also the curvilinear dark structures near the interface between the mass and the liver. These are flow voids from large vessels (yellow arrows).
Fig. 2: This coronal T2-weighted image shows the well-circumscribed mass is slightly hyperintense to liver and the central scar is hyperintense (yellow arrows), whereas the scar was hypointense on the T1-weighted image.
Fig. 3: A sagittal post contrast T1-weighted image was obtained in the delayed phase. The mass is now isointense to liver (red arrows) but the scar is enhancing (yellow arrow). Enhancement on delayed MR differentiates the FNH from fibrolamellar carcinoma, a form of HCC.
Fig. 4 Mass is resected. Note the well demarcated margin surrounding the tumor (red arrows), and the fibrous branching scar (yellow arrows). The parenchyma is a tan color, lighter than the adjacent liver, even in situ.
FNH - Focal Nodular Hyperplasia
• Focal Nodular Hyperplasia
• Choliangiocarcinoma
• Hepatic Adenoma
• Cavernous Hemangioma
• Fibrolamellar carcinoma
A 6 year old girl presents with diffuse abdominal pain.
[See Quiz for this case]

References:

1.	Titelbaum, D.S., et al., Fibrolamellar hepatocellular carcinoma: pitfalls in nonoperative diagnosis. Radiology, 1988. 167(1): p. 25-30.
2.	McLarney, J.K., et al., Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics, 1999. 19(2): p. 453-71.
3.	Wheeler, Y.Y., et al., Metastatic Renal Cell Carcinoma within a Hepatic Focal Nodular Hyperplasia: A Case Report and Review of the Literature. Int J Clin Exp Pathol, 2009. 2(2): p. 190-3.
4.	Demir, H.A., et al., Focal nodular hyperplasia of the liver and elevated alpha fetoprotein level in an infant with isolated hemihyperplasia. J Pediatr Hematol Oncol, 2008. 30(10): p. 775-7.
5.	Lee, I.J., et al., Radiological findings in a case of multiple focal nodular hyperplasia associated with portal vein atresia and portopulmonary hypertension. Korean J Radiol, 2008. 9(4): p. 386-9.
6.	Gutweiler, J.R., et al., Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg, 2008. 43(12): p. 2297-300.
7.	Wasif, N., et al., Focal nodular hyperplasia: report of an unusual case and review of the literature. Am Surg, 2008. 74(11): p. 1100-3.
8.	Portmann, B., et al., Nodular transformation of the liver associated with portal and pulmonary arterial hypertension. Gastroenterology, 1993. 104(2): p. 616-21.
9.	Wang, H.L., et al., Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med, 2008. 132(11): p. 1723-8.
10.	Iyer, A., et al., Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance. Hum Pathol, 2008. 39(9): p. 1370-7.

9.	Stocker, J.T. and K.G. Ishak, Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer, 1981. 48(2): p. 336-45.
10.	Erdogan, D., et al., Morbidity and mortality after liver resection for benign and malignant hepatobiliary lesions. Liver Int, 2009. 29(2): p. 175-80.
11.	Bonney, G.K., et al., Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford), 2007. 9(5): p. 368-372.
12.	Bahirwani, R. and K.R. Reddy, Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther, 2008. 28(8): p. 953-65.


Keywords: 
\-\ patient\\ recovered\\ without\\ recurrence\ \(1\)\
\-\ elevated\\ alpha\\ fetoprotein\\ level\ \(1\)\
\-\ curvilinear\\ dark\\ structures\\ near\ \(1\)\
\-\ arch\\ pathol\\ lab\\ med\ \(0\)\
\-\ sagittal\\ post\\ contrast\\ t1\ \(0\)\
\-\ well\\ demarcated\\ margin\\ surrounding\ \(1\)\
\-\ j\\ pediatr\\ hematol\\ oncol\ \(0\)\
\-\ yellow\\ arrows\\ \\)\\,\\ whereas\ \(0\)\
\-\ hepatic\\ focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ benign\\ hepatocellular\\ mass\\ lesions\ \(1\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ malignant\\ hepatobiliary\\ lesions\ \(1\)\
\-\ yellow\\ arrows\\ \\)\\.\ \(0\)\
\-\ yellow\\ arrow\\ \\)\\.\ \(0\)\
\-\ oxford\\ \\)\\,\\ 2007\ \(0\)\
\-\ useful\\ diagnostic\\ marker\ \(1\)\
\-\ red\\ arrows\\ \\)\\,\ \(0\)\
\-\ distinguishes\\ hepatocellular\\ carcinoma\ \(1\)\
\-\ diffuse\\ abdominal\\ pain\ \(17\)\
\-\ aliment\\ pharmacol\\ ther\ \(0\)\
\-\ korean\\ j\\ radiol\ \(0\)\
\-\ red\\ arrow\\ \\)\\.\ \(0\)\
\-\ pulmonary\\ arterial\\ hypertension\ \(11\)\
\-\ delayed\\ mr\\ differentiates\ \(0\)\
\-\ fairly\\ homogeneous\\ mass\ \(1\)\
\-\ 1\\ \\)\\:\\ p\ \(0\)\
\-\ weighted\\ mr\\ image\ \(0\)\
\-\ j\\ pediatr\\ surg\ \(0\)\
\-\ solitary\\ liver\\ masses\ \(1\)\
\-\ portal\\ vein\\ atresia\ \(1\)\
\-\ fibrous\\ branching\\ scar\ \(1\)\
\-\ 9\\ \\)\\:\\ p\ \(0\)\
\-\ 8\\ \\)\\:\\ p\ \(0\)\
\-\ 5\\ \\)\\:\\ p\ \(0\)\
\-\ 4\\ \\)\\:\\ p\ \(0\)\
\-\ 21\\ pediatric\\ cases\ \(1\)\
\-\ 2\\ \\)\\:\\ p\ \(0\)\
\-\ 12\\ \\)\\:\\ p\ \(0\)\
\-\ 11\\ \\)\\:\\ p\ \(0\)\
\-\ 10\\ \\)\\:\\ p\ \(0\)\
\-\ 1\\ coronal\\ t1\ \(0\)\
\-\ weighted\\ image\\ shows\ \(9\)\
\-\ red\\ arrows\ \(2\)\
\-\ weighted\\ image\ \(194\)\
\-\ hum\\ pathol\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ portopulmonary\\ hypertension\ \(1\)\
\-\ fibrolamellar\\ carcinoma\ \(1\)\
\-\ delayed\\ phase\ \(4\)\
\-\ coronal\\ t2\ \(0\)\
\-\ circumscribed\\ mass\ \(35\)\
\-\ 4\\ mass\ \(0\)\
\-\ term\\ outcome\ \(6\)\
\-\ tan\\ color\ \(1\)\
\-\ see\\ quiz\ \(0\)\
\-\ pathologic\\ correlation\ \(5\)\
\-\ nonoperative\\ diagnosis\ \(1\)\
\-\ liver\\ resection\ \(3\)\
\-\ liver\\ int\ \(3\)\
\-\ liver\\ associated\ \(3\)\
\-\ large\\ vessels\ \(3\)\
\-\ isolated\\ hemihyperplasia\ \(1\)\
\-\ flow\\ voids\ \(48\)\
\-\ central\\ scar\ \(12\)\
\-\ adjacent\\ liver\ \(9\)\
\-\ unusual\\ case\ \(11\)\
\-\ slightly\\ hypointense\ \(7\)\
\-\ slightly\\ hyperintense\ \(16\)\
\-\ review\\ article\ \(1\)\
\-\ note\\ also\ \(3\)\
\-\ case\\ report\ \(33\)\
\-\ j\ \(5023\)\
\-\ t1\ \(2\)\
\-\ well\ \(2069\)\
\-\ benign\ \(377\)\
\-\ mass\ \(4930\)\
\-\ 1\ \(15898\)\
\-\ surg\ \(2352\)\
\-\ shows\ \(903\)\
\-\ scar\ \(217\)\
\-\ portal\ \(147\)\
\-\ liver\ \(830\)\
\-\ 9\ \(4978\)\
\-\ 8\ \(4289\)\
\-\ 5\ \(8237\)\
\-\ 4\ \(7367\)\
\-\ 21\ \(409\)\
\-\ 2\ \(13754\)\
\-\ 12\ \(1027\)\
\-\ 11\ \(860\)\
\-\ 10\ \(1995\)\
\-\ case\ \(1848\)\
\-\ review\ \(141\)\
\-\ report\ \(1067\)\
\-\ note\ \(1539\)\
\-\ hypointense\ \(132\)\
\-\ hyperintense\ \(224\)\
\-\ wheeler\ \(0\)\
\-\ wasif\ \(0\)\
\-\ wang\ \(1\)\
\-\ tumor\ \(1901\)\
\-\ treatment\ \(1387\)\
\-\ titelbaum\ \(0\)\
\-\ study\ \(577\)\
\-\ stocker\ \(0\)\
\-\ situ\ \(87\)\
\-\ significance\ \(29\)\
\-\ resected\ \(107\)\
\-\ references\ \(24\)\
\-\ reddy\ \(1\)\
\-\ radiology\ \(90\)\
\-\ radiologic\ \(108\)\
\-\ radiographics\ \(12\)\
\-\ r\ \(387594\)\
\-\ portmann\ \(0\)\
\-\ pitfalls\ \(5\)\
\-\ parenchyma\ \(367\)\
\-\ ordered\ \(131\)\
\-\ obtained\ \(400\)\
\-\ neuroblastoma\ \(81\)\
\-\ mortality\ \(71\)\
\-\ mclarney\ \(0\)\
\-\ long\ \(1370\)\
\-\ literature\ \(75\)\
\-\ lighter\ \(2\)\
\-\ lee\ \(571\)\
\-\ k\ \(19879\)\
\-\ iyer\ \(0\)\
\-\ isointense\ \(102\)\
\-\ ishak\ \(0\)\
\-\ interface\ \(50\)\
\-\ infant\ \(215\)\
\-\ hpb\ \(0\)\
\-\ hcc\ \(0\)\
\-\ h\ \(223825\)\
\-\ gutweiler\ \(0\)\
\-\ gastroenterology\ \(5\)\
\-\ g\ \(115652\)\
\-\ form\ \(3049\)\
\-\ fnh\ \(0\)\
\-\ fig\ \(144\)\
\-\ excised\ \(32\)\
\-\ even\ \(667\)\
\-\ evaluation\ \(719\)\
\-\ erdogan\ \(0\)\
\-\ enhancing\ \(546\)\
\-\ enhancement\ \(862\)\
\-\ demir\ \(0\)\
\-\ defined\ \(373\)\
\-\ ct\ \(23117\)\
\-\ cancer\ \(694\)\
\-\ bonney\ \(0\)\
\-\ bahirwani\ \(0\)\
\-\ 953\ \(3\)\
\-\ 80\ \(384\)\
\-\ 775\ \(3\)\
\-\ 74\ \(128\)\
\-\ 71\ \(125\)\
\-\ 7\ \(4391\)\
\-\ 65\ \(199\)\
\-\ 616\ \(7\)\
\-\ 6\ \(5312\)\
\-\ 48\ \(260\)\
\-\ 453\ \(4\)\
\-\ 45\ \(319\)\
\-\ 43\ \(166\)\
\-\ 39\ \(286\)\
\-\ 386\ \(8\)\
\-\ 372\ \(5\)\
\-\ 368\ \(7\)\
\-\ 336\ \(3\)\
\-\ 300\ \(40\)\
\-\ 30\ \(631\)\
\-\ 3\ \(8405\)\
\-\ 29\ \(228\)\
\-\ 28\ \(276\)\
\-\ 25\ \(658\)\
\-\ 2297\ \(2\)\
\-\ 2009\ \(58\)\
\-\ 2008\ \(79\)\
\-\ 1999\ \(73\)\
\-\ 1993\ \(25\)\
\-\ 1988\ \(19\)\
\-\ 1981\ \(11\)\
\-\ 190\ \(19\)\
\-\ 19\ \(1027\)\
\-\ 175\ \(13\)\
\-\ 1723\ \(1\)\
\-\ 167\ \(17\)\
\-\ 1370\ \(2\)\
\-\ 132\ \(22\)\
\-\ 1100\ \(3\)\
\-\ 104\ \(39\)\
